Ainvest Option Flow Digest - 2025-12-03 | $156M+ Institutional Bets Signal Year-End Positioning Battle
Smart Money Is Moving Big - Crypto Bulls, Tech Bears, and an FDA Bet That Could Double
Today's Highlights
December 3rd saw $156M+ in unusual options activity across 11 tickers - a significant uptick in institutional positioning as we enter the final month of 2025. The theme? Divergence. While crypto bulls are loading the boat on Bitcoin proxies, sophisticated traders are betting tech's remarkable rally is due for a pause. Meanwhile, the biotech sector witnessed one of the most convicted FDA plays we've seen all year.
Top 3 Trades by Premium:
- COIN - $38M bull call bet targeting crypto's continued momentum
- INTC - $24.4M bear spread betting Intel's 103% rally hits a ceiling at $48
- GBTC - $17.4M calendar roll extending Bitcoin exposure through Q1 2026
Summary Table: Today's Unusual Options Activity
| Ticker | Premium | Expiration | Type | Strategy | What It Means | Key Catalyst |
|---|---|---|---|---|---|---|
| COIN | $38M | Jan 16 (Monthly) | Bullish | Long Calls | Directional bet on crypto rally | Dec 17 product showcase |
| INTC | $24.4M | Mar 20 (Quarterly) | Bearish | Bear Call Spread | Betting rally exhaustion at $48 | Q4 earnings Jan |
| GBTC | $17.4M | Mar 20 (Quarterly) | Bullish | Calendar Roll | Extending Bitcoin bet to Q1 | Grayscale IPO Q1 2026 |
| ALB | $17M | Dec 19 (Weekly) | Bullish | Deep ITM Calls | Locking in lithium rally gains | Q4 earnings Feb 12 |
| CYTK | $15.4M | Jan/Apr (Monthly/Quarterly) | Bullish | Staggered Calls | FDA approval conviction play | FDA Dec 26 PDUFA |
| QQQ | $13M | Dec 5 (2-Day!) | Bearish | Bear Call Spread | Betting on immediate consolidation | Fed meeting Dec 9-10 |
| RDDT | $10.8M | Jan 16 (Monthly) | Bearish | Bear Call Spread | Post-IPO rally exhaustion bet | Q4 earnings Feb 12 |
| KWEB | $6.9M | Mar 20 (Quarterly) | Bullish | Modified Bull Spread | China internet recovery bet | Q4 earnings Feb-Mar |
| LRCX | $6.4M | Jan 16 (Monthly) | Neutral/Bearish | Covered Call/Profit-Taking | De-risking after 116% rally | Q2 earnings Jan 28 |
| BILL | $3.6M | Jan 16 (Monthly) | Bullish | Call Roll | Activist-driven M&A speculation | Q2 earnings Jan 29 |
| SNPS | $2.8M | Dec 2026 (LEAP) | Bearish | Long Puts | Year-long bearish thesis | Earnings Dec 10 |
The Big Story: Crypto Bulls vs. Tech Bears
Today's flow tells a fascinating story of market divergence. On one side, we have massive bullish conviction in crypto - nearly $55M combined in COIN and GBTC calls positioning for Bitcoin's continued strength above $100K. On the other side, $48M in bearish spreads targeting QQQ, RDDT, INTC, and SNPS suggest smart money thinks the rally needs a breather.
The crypto thesis is straightforward: Bitcoin above $93K, post-halving dynamics, ETF inflows, and catalysts like Coinbase's December 17 product showcase (prediction markets, AI assistant "Genie") all support continuation.
The tech bear thesis? After a 22%+ YTD rally in QQQ, 103% surge in INTC, and Reddit's incredible 344% run from IPO, valuations look stretched heading into Fed uncertainty and year-end profit-taking season.
Trade of the Day: CYTK's $15.4M FDA Bet
The most interesting trade today wasn't the largest - it was the most convicted. Someone deployed $15.4M across two tranches betting on Cytokinetics' December 26 FDA decision:
- $10M in $55 Jan calls - Deep ITM positioning to capture immediate approval rally
- $5.4M in $75 Apr calls - OTM bets on post-launch commercial momentum
The Z-score on the April calls? 432.57 - that's 432 standard deviations above normal. We see numbers like this maybe once or twice a year. With 85-90% analyst approval odds for aficamten (their HCM drug), this trader is betting the FDA says yes on December 26.
What makes this interesting: The staggered structure shows sophisticated thinking. The January calls capture the immediate pop, while the April calls bet on something bigger - that aficamten's label will be competitive with Bristol Myers' Camzyos, driving sustained upside into 2026.
What This Means For Different Traders
For YOLO Traders
The Play: CYTK $75 April calls mirror what smart money bought today. The FDA decision is binary - aficamten either gets approved (stock likely $80-100) or it doesn't (stock likely $35-45). This is the definition of a lottery ticket, but one where analysts see 85-90% odds of winning.
Risk Warning: Binary events are unpredictable. The FDA has surprised before. Never bet more than you can afford to lose on any single catalyst.
Alternative: COIN January $280 calls offer leveraged exposure to crypto without the binary risk. The $38M flow suggests serious institutional conviction.
For Swing Traders
Best Setup: KWEB March $39/$44 call spread. The $6.9M flow today shows institutions methodically accumulating over 26 minutes - classic smart money behavior. China stimulus, Q4 earnings from Alibaba/Tencent, and trade de-escalation all support upside. Breakeven at $40.04 (7.7% move) is achievable.
Risk/Reward: ~3:1 if KWEB hits $44 by March. Defined risk with spread structure.
Avoid: The QQQ 2-day bear spread. That's an institutional game with $137M max loss potential - not for swing traders.
For Premium Collectors
Best Setup: INTC March $48/$55 bear call spread mirrors the $24.4M trade today. After a 103% YTD rally, Intel faces significant resistance at $48 where 46,000 contracts sit in open interest. Collect $5.6M in premium (on institutional scale) betting the stock stays below $48 through March.
Retail Version: Sell INTC March $48 calls, buy $52 calls. Collect ~$1.50-2.00 credit on $4 width spread.
Why This Works: The gamma wall at $48 creates natural resistance. Q4 earnings and 18A production updates are catalyst risks, but the spread width provides cushion.
For Entry-Level Option Traders
Educational Opportunity: Watch the LRCX trade unfold. Someone sold $6.4M of deep ITM calls at $136 strike with stock at $158. This is textbook covered call/profit-taking - they're locking in 116% YTD gains while generating income.
What to Learn:
- Deep ITM calls behave like stock (high delta)
- Selling calls caps upside but generates immediate cash
- Timing matters - this trade expires BEFORE Q2 earnings, avoiding event risk
Paper Trade Idea: Practice the BILL $52.5 January calls. The roll pattern shows how institutions adjust positions as stock price moves. Watch how the position evolves through year-end.
Upcoming Catalysts to Watch
This Week (Dec 3-7)
| Date | Event | Tickers Affected |
|---|---|---|
| Dec 5 | QQQ weekly options expiration | QQQ (bear spread expires!) |
| Dec 5 | Jobs report | All equities |
Next Week (Dec 8-14)
| Date | Event | Tickers Affected |
|---|---|---|
| Dec 9-10 | FOMC meeting & rate decision | QQQ, all tech |
| Dec 10 | SNPS Q4 earnings | SNPS ($2.8M put position) |
| Dec 12 | Nasdaq-100 reconstitution | QQQ |
Later December
| Date | Event | Tickers Affected |
|---|---|---|
| Dec 17 | Coinbase product showcase | COIN |
| Dec 18 | November CPI report | All equities |
| Dec 19 | Triple witch monthly OPEX | ALB, all December expirations |
| Dec 26 | CYTK FDA PDUFA decision | CYTK (biggest binary event!) |
January 2026
| Date | Event | Tickers Affected |
|---|---|---|
| Jan 16 | January monthly OPEX | CYTK, RDDT, BILL, LRCX, COIN |
| Jan 28 | LRCX Q2 earnings | LRCX |
| Jan 29 | BILL Q2 earnings | BILL |
| Late Jan | INTC Q4 earnings | INTC |
Risk Management Reminders
Remember: Unusual activity is NOT a buy signal. These trades represent one side of a transaction - the other side took the opposite bet. Smart money is often wrong, and even when right, timing matters enormously.
Position sizing rules:
- Binary events (FDA decisions): 2-5% max portfolio allocation
- Defined-risk spreads: 3-5% of portfolio per trade
- Naked directional bets: 1-2% of portfolio
Today's biggest risk: The QQQ bear spread shows institutions expect consolidation, but they're risking $137M to make $13M. That 10:1 risk/reward tells you even smart money thinks this is a low-probability bet. Don't assume they're always right.
Patience pays: The GBTC calendar roll shows how institutions think - they paid $6.6M NET DEBIT to extend their position from January to March. They're not trying to time the exact bottom or top. They're positioning for sustained moves over months, not days.
Today's Flow Summary
- Total Premium: $156M+
- Bullish Flow: ~$81M (COIN, GBTC, ALB, CYTK, KWEB, BILL)
- Bearish Flow: ~$54M (INTC, QQQ, RDDT, SNPS)
- Neutral/Profit-Taking: ~$21M (LRCX)
The bulls and bears are nearly balanced, but the CONVICTION is skewed bullish. The largest single trades (COIN $38M, GBTC $17.4M) are betting on upside, while bearish trades are more about hedging and profit-protection than aggressive speculation.
Stay sharp, manage risk, and remember - the best trade is often the one you don't make.
This digest is for educational purposes only and should not be construed as financial advice. Options trading involves substantial risk of loss. Always do your own research and consider consulting a licensed financial advisor before trading.
About Ainvest Option Flow: We track real-time unusual options activity across U.S. markets, identifying trades where premium, size, and positioning suggest institutional conviction. Our analysis combines quantitative signals with fundamental catalyst research to provide actionable context for traders at all levels.